openSUSE Leap 42.3: openSUSE-SU-2019:0348-1 Important: ovmf Security Fix
opensuse
March 19, 2019
An update that fixes three vulnerabilities is now available.
Description
This update for ovmf fixes the following issues:
Security issues fixed:
- CVE-2018-12180: Fixed a buffer overflow in BlockIo service, which could
lead to memory read/write overrun (bsc#1127820).
- CVE-2018-12178: Fixed an improper DNS check upon receiving a new DNS
packet (bsc#1127821).
- CVE-2018-3630: Fixed a logic error in FV parsing which could allow a
local attacker to bypass the chain of trust checks (bsc#1127822).
This update was imported from the SUSE:SLE-12-SP3:Update update project.
Topics Covered
Patch
Patch Instructions:
To install this openSUSE Security Update use the SUSE recommended installation methods
like YaST online_update or "zypper patch".
Alternatively you can run the command listed for your product:
- openSUSE Leap 42.3:
zypper in -t patch openSUSE-2019-348=1
Package List
- openSUSE Leap 42.3 (i586 x86_64):
ovmf-2017+git1492060560.b6d11d7c46-16.1
ovmf-tools-2017+git1492060560.b6d11d7c46-16.1
- openSUSE Leap 42.3 (x86_64):
qemu-ovmf-x86_64-debug-2017+git1492060560.b6d11d7c46-16.1
- openSUSE Leap 42.3 (noarch):
qemu-ovmf-ia32-2017+git1492060560.b6d11d7c46-16.1
qemu-ovmf-x86_64-2017+git1492060560.b6d11d7c46-16.1
References
https://www.suse.com/security/cve/CVE-2018-12178.html
https://www.suse.com/security/cve/CVE-2018-12180.html
https://www.suse.com/security/cve/CVE-2018-3630.html
https://bugzilla.suse.com/1127820
https://bugzilla.suse.com/1127821
https://bugzilla.suse.com/1127822
--
PREVIOUS
NEXT
Severity
important
Lowest
Low
Medium
High
Critical
Announcement ID: openSUSE-SU-2019:0348-1
Rating: important
Affected Products:
openSUSE Leap 42.3
Topics Covered
Get the latest News and Insights
Get the latest Linux and open source security news straight to your inbox.
Related News
Powered By
Linux Security - Your source for Top Linux News, Advisories, HOWTOs and Feature Releases
QUICK LINKS
subscribe to newsletters!
Like staying secure? So do we.
Sign up for updates, tips, and alerts!